Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by RobHabson Jan 09, 2020 2:21pm
249 Views
Post# 30535583

LEAK

LEAKThose who were shareholders of Prometic will surely remember that before getting the bad news from the FDA/additional check point requested,  SP (PLI) steadily declined in the weeks preceding the announcement. Clearly some people were aware of the postponement (leak).We have seen much the same situation for some time with liminal (LMNL) but in an opposite direction, clearly some people are aware of a new to come ... it looks good for long-term investors. We should hear from the company shortly !
<< Previous
Bullboard Posts
Next >>